Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 5 | 2024 | 1033 | 1.840 |
Why?
|
| Prognosis | 8 | 2024 | 707 | 1.340 |
Why?
|
| Computational Biology | 3 | 2020 | 275 | 1.330 |
Why?
|
| Genomics | 3 | 2020 | 201 | 1.320 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 336 | 1.290 |
Why?
|
| MicroRNAs | 5 | 2023 | 386 | 1.230 |
Why?
|
| Pulmonary Fibrosis | 1 | 2022 | 25 | 0.900 |
Why?
|
| Echocardiography | 4 | 2018 | 144 | 0.890 |
Why?
|
| Sequence Analysis, RNA | 3 | 2021 | 104 | 0.870 |
Why?
|
| Sulfites | 1 | 2022 | 5 | 0.860 |
Why?
|
| Exosomes | 1 | 2023 | 97 | 0.860 |
Why?
|
| Transcription Factors | 2 | 2024 | 653 | 0.840 |
Why?
|
| Organ Specificity | 1 | 2020 | 123 | 0.770 |
Why?
|
| Immunotherapy | 1 | 2021 | 91 | 0.770 |
Why?
|
| Metabolome | 1 | 2019 | 47 | 0.710 |
Why?
|
| Myocardial Perfusion Imaging | 2 | 2018 | 6 | 0.710 |
Why?
|
| Research | 1 | 2020 | 159 | 0.700 |
Why?
|
| Phospholipids | 6 | 2021 | 68 | 0.680 |
Why?
|
| Humans | 32 | 2024 | 34853 | 0.680 |
Why?
|
| Amino Acids | 1 | 2019 | 139 | 0.680 |
Why?
|
| Lyases | 1 | 2019 | 51 | 0.680 |
Why?
|
| DNA Methylation | 1 | 2022 | 301 | 0.670 |
Why?
|
| Sulfur Hexafluoride | 5 | 2018 | 5 | 0.530 |
Why?
|
| Thrombosis | 1 | 2015 | 61 | 0.510 |
Why?
|
| Mutation | 1 | 2019 | 1023 | 0.490 |
Why?
|
| Contrast Media | 6 | 2018 | 95 | 0.490 |
Why?
|
| Aged | 12 | 2020 | 6448 | 0.480 |
Why?
|
| Ultrasonography, Mammary | 4 | 2022 | 6 | 0.480 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 413 | 0.470 |
Why?
|
| Breast Neoplasms | 5 | 2023 | 1426 | 0.470 |
Why?
|
| Female | 23 | 2023 | 19873 | 0.460 |
Why?
|
| Predictive Value of Tests | 5 | 2021 | 424 | 0.460 |
Why?
|
| Biomedical Research | 1 | 2016 | 371 | 0.430 |
Why?
|
| Middle Aged | 12 | 2020 | 9642 | 0.410 |
Why?
|
| Male | 14 | 2021 | 18870 | 0.360 |
Why?
|
| Reproducibility of Results | 6 | 2020 | 901 | 0.360 |
Why?
|
| Chickens | 2 | 2021 | 123 | 0.350 |
Why?
|
| Aged, 80 and over | 8 | 2020 | 2333 | 0.340 |
Why?
|
| T-Lymphocytes | 2 | 2022 | 341 | 0.330 |
Why?
|
| Heart Neoplasms | 2 | 2018 | 7 | 0.310 |
Why?
|
| Sensitivity and Specificity | 6 | 2022 | 555 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 781 | 0.280 |
Why?
|
| Chromatin | 2 | 2024 | 164 | 0.280 |
Why?
|
| Image Enhancement | 2 | 2015 | 41 | 0.260 |
Why?
|
| Hemolysis | 1 | 2023 | 39 | 0.240 |
Why?
|
| Fasting | 1 | 2023 | 50 | 0.240 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2024 | 52 | 0.240 |
Why?
|
| Lymphatic Metastasis | 2 | 2022 | 63 | 0.230 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 32 | 0.230 |
Why?
|
| Animals | 10 | 2022 | 14307 | 0.230 |
Why?
|
| Melanoma | 1 | 2024 | 91 | 0.220 |
Why?
|
| Metabolomics | 2 | 2021 | 76 | 0.220 |
Why?
|
| Methyltransferases | 1 | 2022 | 56 | 0.220 |
Why?
|
| Adult | 10 | 2023 | 11034 | 0.210 |
Why?
|
| Workflow | 1 | 2022 | 19 | 0.210 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 106 | 0.210 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2021 | 10 | 0.210 |
Why?
|
| Fanconi Anemia | 1 | 2021 | 12 | 0.210 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2021 | 9 | 0.210 |
Why?
|
| CpG Islands | 1 | 2022 | 91 | 0.210 |
Why?
|
| Colonic Neoplasms | 1 | 2024 | 181 | 0.210 |
Why?
|
| Endometrium | 1 | 2022 | 57 | 0.210 |
Why?
|
| Immunologic Factors | 1 | 2021 | 44 | 0.200 |
Why?
|
| Relaxin | 1 | 2021 | 10 | 0.200 |
Why?
|
| Mevalonic Acid | 1 | 2021 | 9 | 0.200 |
Why?
|
| Ethanolamine | 1 | 2021 | 8 | 0.200 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2020 | 9 | 0.200 |
Why?
|
| Up-Regulation | 2 | 2020 | 490 | 0.190 |
Why?
|
| Meta-Analysis as Topic | 1 | 2020 | 27 | 0.190 |
Why?
|
| Mixed Function Oxygenases | 1 | 2020 | 29 | 0.190 |
Why?
|
| Microarray Analysis | 1 | 2020 | 61 | 0.190 |
Why?
|
| MAP Kinase Signaling System | 1 | 2022 | 162 | 0.190 |
Why?
|
| RNA | 1 | 2022 | 234 | 0.190 |
Why?
|
| Neovascularization, Pathologic | 2 | 2013 | 122 | 0.190 |
Why?
|
| DNA Repair | 1 | 2021 | 181 | 0.190 |
Why?
|
| Mice, Knockout | 2 | 2021 | 897 | 0.190 |
Why?
|
| Databases, Genetic | 1 | 2020 | 90 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2023 | 528 | 0.180 |
Why?
|
| Teratogens | 1 | 2019 | 12 | 0.180 |
Why?
|
| Lung | 1 | 2022 | 413 | 0.180 |
Why?
|
| Mice | 5 | 2022 | 5668 | 0.180 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 97 | 0.180 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 281 | 0.180 |
Why?
|
| Stomach Neoplasms | 1 | 2021 | 192 | 0.180 |
Why?
|
| Survival Analysis | 1 | 2020 | 322 | 0.180 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 67 | 0.180 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 211 | 0.180 |
Why?
|
| DNA Damage | 1 | 2021 | 341 | 0.170 |
Why?
|
| Cell Culture Techniques | 1 | 2019 | 136 | 0.170 |
Why?
|
| Membrane Proteins | 1 | 2022 | 486 | 0.170 |
Why?
|
| Egg Shell | 1 | 2018 | 8 | 0.170 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 195 | 0.170 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 203 | 0.170 |
Why?
|
| Selenoproteins | 1 | 2021 | 151 | 0.170 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 114 | 0.170 |
Why?
|
| Prospective Studies | 5 | 2022 | 1353 | 0.170 |
Why?
|
| Uterus | 1 | 2018 | 54 | 0.170 |
Why?
|
| Caenorhabditis elegans | 1 | 2019 | 74 | 0.170 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 292 | 0.160 |
Why?
|
| Risk Assessment | 2 | 2019 | 727 | 0.160 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 221 | 0.160 |
Why?
|
| Selenium | 1 | 2019 | 144 | 0.150 |
Why?
|
| Disease | 1 | 2016 | 18 | 0.150 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 522 | 0.150 |
Why?
|
| Signal Transduction | 3 | 2021 | 1802 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 592 | 0.140 |
Why?
|
| Observer Variation | 1 | 2015 | 57 | 0.130 |
Why?
|
| Heart Atria | 1 | 2015 | 27 | 0.130 |
Why?
|
| Young Adult | 4 | 2020 | 4012 | 0.130 |
Why?
|
| Arteries | 1 | 2015 | 67 | 0.130 |
Why?
|
| Ultrasonography | 4 | 2020 | 115 | 0.130 |
Why?
|
| Norepinephrine | 1 | 2014 | 107 | 0.120 |
Why?
|
| Ventricular Function, Left | 1 | 2015 | 104 | 0.120 |
Why?
|
| Heart Ventricles | 1 | 2015 | 121 | 0.120 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 180 | 0.120 |
Why?
|
| Atherosclerosis | 1 | 2014 | 131 | 0.110 |
Why?
|
| Acute Coronary Syndrome | 1 | 2013 | 35 | 0.110 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2012 | 22 | 0.110 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2012 | 34 | 0.110 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 61 | 0.110 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 147 | 0.100 |
Why?
|
| Embryo, Mammalian | 2 | 2022 | 152 | 0.100 |
Why?
|
| Oviposition | 2 | 2021 | 12 | 0.090 |
Why?
|
| Embryonic Development | 2 | 2021 | 73 | 0.090 |
Why?
|
| Carotid Stenosis | 1 | 2009 | 13 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2021 | 283 | 0.080 |
Why?
|
| Adolescent | 2 | 2015 | 5035 | 0.080 |
Why?
|
| Child | 1 | 2015 | 2875 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2023 | 600 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2022 | 1152 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2020 | 1961 | 0.060 |
Why?
|
| Pancreas | 1 | 2023 | 32 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 66 | 0.060 |
Why?
|
| Genome, Viral | 1 | 2023 | 103 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2023 | 135 | 0.050 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2022 | 14 | 0.050 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2022 | 27 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2023 | 271 | 0.050 |
Why?
|
| Genomic Instability | 1 | 2021 | 34 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 57 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2022 | 67 | 0.050 |
Why?
|
| Eggs | 1 | 2021 | 6 | 0.050 |
Why?
|
| Oviducts | 1 | 2021 | 13 | 0.050 |
Why?
|
| Ethanolamines | 1 | 2021 | 12 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2022 | 298 | 0.050 |
Why?
|
| Phosphatidylethanolamines | 1 | 2021 | 22 | 0.050 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2021 | 19 | 0.050 |
Why?
|
| Lipogenesis | 1 | 2021 | 18 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2022 | 222 | 0.050 |
Why?
|
| Cattle | 1 | 2022 | 472 | 0.050 |
Why?
|
| DNA Replication | 1 | 2021 | 148 | 0.050 |
Why?
|
| Proteomics | 1 | 2023 | 302 | 0.050 |
Why?
|
| Blastocyst | 1 | 2021 | 48 | 0.050 |
Why?
|
| Glycolysis | 1 | 2021 | 66 | 0.050 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 65 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2021 | 88 | 0.050 |
Why?
|
| Cell Aggregation | 1 | 2019 | 14 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2023 | 638 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2019 | 67 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2019 | 196 | 0.040 |
Why?
|
| Molting | 1 | 2018 | 8 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 115 | 0.040 |
Why?
|
| Protein Binding | 1 | 2020 | 913 | 0.040 |
Why?
|
| Pregnancy | 1 | 2022 | 1503 | 0.040 |
Why?
|
| Algorithms | 1 | 2019 | 435 | 0.040 |
Why?
|
| Base Sequence | 1 | 2018 | 932 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2018 | 420 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2019 | 562 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 1530 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2019 | 1442 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 1422 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 1149 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 1300 | 0.030 |
Why?
|
| Models, Biological | 1 | 2018 | 642 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2014 | 10 | 0.030 |
Why?
|
| Reference Values | 1 | 2015 | 204 | 0.030 |
Why?
|
| China | 1 | 2015 | 178 | 0.030 |
Why?
|
| Rabbits | 1 | 2014 | 278 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 164 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 213 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 423 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2009 | 111 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 3414 | 0.020 |
Why?
|